Attendees at this week’s prestigious Saudi Ophthalmology annual meeting – So2023 (link) from 19-21st October in Riyadh will learn about the latest clinical research outcomes
NuVision Biotherapies is honoured to make its inaugural appearance at the European Society of Cataract & Refractive Surgeons (ESCRS) prestigious 41st Congress, taking place in
Study demonstrates the benefit of OmniLenz applied Omnigen in the early management of acute chemical eye injuries (CEI) in the first prospective study of its
Last week, attendees at the 2023 European Society of Ophthalmology (SOE) 15-17 June, Prague (https://soe2023.soevision.org) had the opportunity to learn about the latest clinical studies
Two Studies Find NuVision’s Omnigen Amniotic Membrane Effective in Improving Dry Eye Disease Symptomology Management of DED symptomology is challenging. One in four of us
People across the West Midlands and surrounding area have the opportunity to take part in an exciting next phase clinical study in an effort to
NuVision are announced as a winner of two awards. One which celebrates our collaboration with Aston University Vision Science Group and other second for providing
NuVision – a Nottingham-based company with a product that speeds up healing of eye conditions – has raised a further £1.1m investment. The funding has
Two consultant ophthalmic surgeons will lead the teaching day on the application of dried amniotic membrane in a range of ophthalmic presentations The session will
Webinar round-up: Five clinicians from four NHS centres present on their case report applications of amniotic membrane in different ophthalmic conditions in a webinar sponsored
NuVision Biotherapies Ltd
Ocular Healing, naturally
NuVision Biotherapies Ltd
MediCity
D6 Building
Thane Road
Nottingham
NG90 6BH
Opening: 9am-5pm, Mon-Fri
© 2020 NuVision Biotherapies Ltd
All rights reserved
Registered in England & Wales. Company N. | VAT Registration: 222465234
Terms and Conditions | Cookie Policy | Privacy Policy
Website by Clifton Media
